Recent Alzheimer’s drug disappointment illuminates pathway for progress against the…
Credit: UsA2 In a letter released today by UsAgainstAlzheimer's, Co-Founder and Chairman George Vradenburg said the negative clinical trial of a once-promising Alzheimer's drug, Solanezumab..















